Hoops, The NGIO IPO cash $50 million will belon
Post# of 36536
(Total Views: 556)
Posted On: 06/25/2021 10:58:25 AM
Hoops,
The NGIO IPO cash $50 million will belong solely to NuGenerex. Generex (GNBT) will not be able to touch a dime of it. That is why it will be imperative for GNBT to get their Class A NGIO shares to reach its maximum value ASAP. That could be by an early conversion to Class B shares or keeping the Class A shares separate but moving them to NASDAQ if the OTC pps is sufficient to allow that move. Either way, I am quite confident that the Class A shares will become very valuable with in a year’s time.
Also, another thought. This board has discussed the NGIO value to GNBT by selling the NGIO shares. But, when NGIO becomes profitable, (for it must or it will go out of business), instead of selling shares, since GNBT controls NGIO (with the 300M voting shares), it could simply issue a dividend. A mere $1/share dividend would generate $64+ million in cash for GNBT to use for the benefit of its other held companies.
The NGIO IPO cash $50 million will belong solely to NuGenerex. Generex (GNBT) will not be able to touch a dime of it. That is why it will be imperative for GNBT to get their Class A NGIO shares to reach its maximum value ASAP. That could be by an early conversion to Class B shares or keeping the Class A shares separate but moving them to NASDAQ if the OTC pps is sufficient to allow that move. Either way, I am quite confident that the Class A shares will become very valuable with in a year’s time.
Also, another thought. This board has discussed the NGIO value to GNBT by selling the NGIO shares. But, when NGIO becomes profitable, (for it must or it will go out of business), instead of selling shares, since GNBT controls NGIO (with the 300M voting shares), it could simply issue a dividend. A mere $1/share dividend would generate $64+ million in cash for GNBT to use for the benefit of its other held companies.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼